ArticleHematology reports2016

Brentuximab Vedotin Therapy for Cutaneous Lesions in T-Prolymphocytic Leukemia: A Case Report.

Jordan Senchak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.